Kevin Rakin

Verified
Sole Member of Highcape Capital, LLC, Highcape Capital at Highcape Partners ManagementListed on SEC Form ADVWestport, United States
Claim this profile
Sign up to save
Cold

Check Size

Not yet known

Reliability Score

🎯89% of deals in Healthcare

Investment Timeline

Allyx Therapeutics
Board seat (SEC Form D)Source
Since May 2026
Company last raised May 2026
CapeHaven Holding
Board seat (SEC Form D)Source
Since Jul 2025
Company last raised Jul 2025
Modifi Biosciences
Board seat (SEC Form D)Source
Since Apr 2022
Company last raised Aug 2024
Aztek Bio
Board seat (SEC Form D)Source
Since Nov 2021
Company last raised Nov 2021
Alphina Therapeutics
Board seat (SEC Form D)Source
Since Sep 2021
Company last raised Mar 2026
Cybrexa Holding
Board seat (SEC Form D)Source
Since Jan 2020
Company last raised Jun 2022
Convexity Scientific
Board seat (SEC Form D)Source
Since Oct 2019
Company last raised Aug 2026
CyOmics
Board seat (SEC Form D)Source
Since Jan 2017
Company last raised Jan 2017
CyOmics
Board seat (SEC Form D)Source
Since Mar 2015
Company last raised Mar 2015

Portfolio Breakdown

By Sector

Healthcare8 deals · 89%
Other1 deal · 11%

By Stage

9 tracked deals2 sectors · 0 stages

Deal Velocity

Avg Deals / Year
0.8
Avg Deal Size
Unknown
Largest Deal
Allyx Therapeutics
Unknown
YoY Trend
Steady

Deals Per Year

1
15
0
16
1
17
0
18
1
19
1
20
2
21
1
22
0
23
0
24
1
25
1
26
9 total deals tracked2015–2026

Investment Activity Map

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Less
More

Current Fund Status

Fund Name
Highcape Special Opportunities 4-B, LLC
Reported Size
$1.7M

Co-Investors

No co-investment data available yet.

Warm Intro Paths

Sign in to discover warm intro paths

Sign in